Susquehanna International Group, LLP Purple Biotech Ltd. Transaction History

Susquehanna International Group, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.39 - $4.15 $31,395 - $54,514	-13,136 Reduced 53.62%	11,361 $27,000
Q1 2022 May 16, 2022	SELL	$2.45 - $4.3 $24,078 - $42,260	-9,828 Reduced 28.63%	24,497 $97,000
Q4 2021 Feb 14, 2022	BUY	$3.75 - $4.67 $51,172 - $63,726	13,646 Added 65.99%	34,325 $134,000
Q4 2020 Feb 16, 2021	BUY	$3.81 - $4.73 $78,786 - $97,811	20,679 New	20,679 $79,000

2.64M

6.6K

Ticker PPBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,303,300
Market Cap $6.77M
Description
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.